impact factor, citescore
logo
 

Clinical aspects

 

Prevalence of sicca syndrome in the Peruvian population


1, 2, 3, 4, 5

 

  1. Department of Dental Clinical Specialties, School of Dentistry, Complutense University, Madrid; and Department of Investigation, Innovación y Desarrollo Perú SAC, Ancash, Perú. lam204@hotmail.com
  2. Department of Dental Clinical Specialties, School of Dentistry, Complutense University, Madrid, Spain.
  3. Faculty of Medical Sciences, Santiago Antúnez de Mayolo University, Ancash Peru.
  4. Department of Dental Clinical Specialties, School of Dentistry, Complutense University, Madrid, Spain.
  5. Department of Dental Clinical Specialties, School of Dentistry, Complutense University, Madrid, Spain.

CER11446
2019 Vol.37, N°3 ,Suppl.118
PI 0065, PF 0069
Clinical aspects

Free to view
(click on article PDF icon to read the article)

PMID: 30299247 [PubMed]

Received: 07/06/2018
Accepted : 02/08/2018
In Press: 20/09/2018
Published: 27/08/2019

Abstract

OBJECTIVES:
Sjögren’s syndrome is a complex and heterogeneous autoimmune disease characterised by ocular and oral dryness (1), which mainly affects the exocrine glands. The objective of this study was to determine the prevalence of sicca syndrome (SS) in the Peruvian population. The age and gender of patients with SS and their national prevalence and in each of the departments were defined.
METHODS:
This was a cross-sectional prevalence study. All the people for whom the Ministry of Health (MINSA) in Peru covered health treatments from January to December 2016 were taken into account. The patients with SS were either newly or previously diagnosed with sicca syndrome (Sjögren’s) according to the international classification of diseases version 10 (ICD-10) of the World Health Organization (WHO). The prevalence was determined considering the number of cases of SS in the total population registered by the Ministry of Health (MINSA).
RESULTS:
1,301 cases of SS were observed in a total population of 15,417,345 people served in 25 territories. The prevalence of SS in this population was 0.0084%, the prevalence rate was 8.4 cases per 100,000 persons (95% CI: 7.99-8.91). The prevalence of SS was higher in the territories of Tacna, Lima, La Libertad, Arequipa, Callao, and Apurímac.
CONCLUSIONS:
The results of this study show the prevalence of SS in the Peruvian population and serve to strengthen the health strategies of rheumatology, ophthalmology, and oral health to improve the diagnosis, treatment, follow-up of the disease, and the quality of life of patients with SS.

Rheumatology Article